Fund raising
Jamie Christian, a well-known bodybuilder and Gladiators star, is using his platform to raise awareness about prostate cancer and encourage men to get regular check-ups. During Men's Health Week, he spoke about his family's experience with the disease and emphasized the importance of early detection through
Cancer research
Research on prostate cancer has been gaining traction, with a new study shedding light on the potential uses of immunotherapy in treating this disease. Immunotherapy, which harnesses the power of the immune system to fight cancer, has been shown to be effective in treating melanoma and lung cancer, but its
Fund raising
Alastair Fraser, a 72-year-old man from West Linton, has been battling stage four cancer for nearly four years. Despite this, he has found solace in cycling and will participate in Sir Chris Hoy's Tour de 4 challenge on September 7, raising funds for Prostate Cancer UK. Fraser'
Cancer research
Research from the University of Gothenburg in Sweden has highlighted the impact of socioeconomic factors and urbanisation on participation in organised prostate cancer screening. In a study published in PLOS One, researchers examined the associations between neighbourhood characteristics and participation in a population-based organised prostate cancer testing (OPT) programme among
Fund raising
Gladiators star Jamie Christian is using his platform to raise awareness about prostate cancer, which he believes can affect anyone without warning signs. Having lost his uncle to the disease, Christian is advocating for men to get regular PSA blood tests to check their prostate specific antigens levels, a crucial
Fund raising
Gladiators star Jamie Christian, also known as Giant, has used his platform to raise awareness about the importance of prostate cancer screening during Men's Health Week. Christian's personal experience with prostate cancer, particularly his uncle's battle with the disease, has made him a passionate
Cancer research
Florida Cancer Specialists & Research Institute (FCS), a leading community oncology practice, has continued to enhance its genomic testing capabilities to advance cancer care, improve cure rates, and enhance patient experience. The practice has made significant progress in expanding its comprehensive genomic testing menu, which includes liquid biopsy, a blood
Cancer research
A recent study published in The Prostate has investigated the association between thromboembolic events (TE) and castration-resistant prostate cancer (CRPC) patients receiving oral androgen receptor pathway inhibitors (ARPi) compared to those undergoing chemotherapy. The research used the Surveillance, Epidemiology, and End Results (SEER) Medicare Linked Database from 2012 to 2016,
Cancer research
British scientists have used artificial intelligence (AI) to identify which men with high-risk prostate cancer could most benefit from a hormone treatment that is currently denied by the NHS in England. The study found that one in four men could have their risk of death halved if given the treatment,
Cancer research
Researchers say that an AI-powered test could help doctors determine which patients with advanced prostate cancer will benefit most from a life-extending treatment that is currently not approved for use in England. The study, led by The Institute of Cancer Research, London, and University College London (UCL), used images of
Cancer research
A recent study published in The World Journal of Men's Health has identified genes associated with prostate cancer, providing potential prognostic predictors and therapeutic targets for the disease. The research, conducted at Nanjing Medical University, aimed to investigate prognostic genes related to capsular invasion in prostate cancer by
Cancer research
Research from the Institute for Cancer Research and Treatment (IRCCS) San Raffaele Scientific Institute in Milan, Italy, has highlighted the potential of emerging imaging-guided technologies to improve the precision and efficacy of robot-assisted prostate cancer surgery. According to the study, prostate-specific membrane antigen radioguided surgery (PSMA-RGS) and augmented reality (AR)
